Pfizer Inc. closed $4.92 short of its 52-week high ($31.54), which the company reached on July 30th.
Pfizer has agreed to reimburse BioNTech for $364.5 million of the claimed royalties paid to NIH and $170.0 million of the claimed royalties paid to the University of Pennsylvania. Write to Dean Seal ...
Concurrently, the company has amended its license agreements to provide for a low single-digit percentage royalty on Net Sales of Licensed Products for 2024 onwards. Currently, BioNTech's stock is ...
In a regulatory filing, BioNTech (BNTX) said, “BioNTech previously disclosed that it was in discussions with the University of Pennsylvania ...
U.S. stock index futures on Friday slipped, with another quiet holiday session expected. Here are some stocks to watch on Friday: ...
BioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...
Investors love dividend stocks, especially the blue-chip variety because they ... and paints and coatings applications.